Entry |
|
Name |
Farletuzumab ecteribulin (USAN) |
Formula |
C6466H9928N1716O2020S42. (C70H100N7O21)x
|
Efficacy |
Antineoplastic |
Type |
Antibody-drug conjugate |
Comment |
Treatment of cancer
|
Target |
|
Pathway |
|
Brite |
Target-based classification of drugs [BR:br08310]
Transporters
Other transporters
Others
FOLR1
D12183 Farletuzumab ecteribulin (USAN)
Not elsewhere classified
Cellular process
Cytoskeleton
TUBB
D12183 Farletuzumab ecteribulin (USAN)
|
Other DBs |
|